News In blink-and-miss-it moment, Harris vows to expand OOP cap The US Presidential debate barely mentioned pharma topics, but Harris did have one notable sound bite toward the very end of the night.
News Ipsen charts $1.75bn course for Kartos acquisition Ipsen has agreed to buy cancer biotech Kartos Therapeutics for $450m upfront, adding a late-stage drug in the challenging MDM2 inhibitor class.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.